The European Union has initiated an investigation into China’s procurement of medical devices, aiming to protect local manufacturers from unfair competition. The probe is part of a series of investigations into Chinese clean tech producers dumping subsidized goods in the EU market and Chinese-owned companies benefiting from subsidies while operating within the EU.
The European Commission, responsible for the investigations, aims to prevent market distortion and unfair competition. The probe into Chinese public procurement of medical devices, launched under the EU International Procurement Instrument, seeks to prevent countries from favoring domestic suppliers unfairly.
If the Commission finds that European suppliers do not have fair access to the Chinese market, it could impose restrictions on Chinese medical device companies bidding in EU public tenders. This investigation marks the first under the EU International Procurement Instrument, highlighting the EU’s commitment to ensuring a level playing field for all suppliers.
The EU’s efforts to investigate Chinese subsidies and imports reflect its commitment to safeguarding the interests of European manufacturers and ensuring fair competition in the market. Stay tuned for updates on the outcomes of these investigations and their potential impact on the global trade landscape.